Clinical Trial Result Information

Protocol number
BO18414

Title of Study
A Study of Ocrelizumab in Patients with Follicular Non-Hodgkin’s Lymphoma (NHL)

Sponsor
F Hoffmann-La Roche Ltd/Global Development

Company division
Pharmaceutical

Product name
ocrelizumab

Therapeutic area
Non-Hodgkin’s Lymphoma

Clinical study summary
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.

Phase of development
II

Date of report
To be Published

Click here for the protocol registry listing of this trial.